You are now leaving www.hulio.com, a Biocon Biologics website. The website you are about to access is not owned or controlled by Biocon Biologics Inc.
Biocon Biologics Inc. assumes no responsibility for and makes no warranties or representation of any kind as to the accuracy, currency, or completeness any information contained in such third-party website, including any third-party social media or mobile application platform. Inclusion of any third-party link on this website does not imply an endorsement or recommendation by Biocon Biologics, and a link to this website from another website does not imply a relationship between Biocon Biologics and any third party. Your use of any such third-party site or platform is at your own risk and will be governed by such third party's terms and policies (including its privacy policy). Biocon Biologics shall not be liable for any direct, indirect, consequential, incidental or punitive damages arising out of access to, use of, or inability to use such third-party website, or any errors or omissions in the content thereof.
APPROVED USES
HULIO is a prescription medicine used:
- Moderate to severe rheumatoid arthritis (RA) in adults. HULIO can be used alone, with methotrexate, or with certain other medicines. HULIO may prevent further damage to your bones and joints and may help your ability to perform daily activities.
- Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. HULIO can be used alone or with methotrexate.
- Psoriatic arthritis (PsA) in adults. HULIO can be used alone or with certain other medicines. HULIO may prevent further damage to your bones and joints and may help your ability to perform daily activities.
- Ankylosing spondylitis (AS) in adults.
- Moderate to severe hidradenitis suppurativa (HS) in adults.
- To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older.
- To treat moderate to severe ulcerative colitis (UC) in adults. It is not known if adalimumab products are effective in people who stopped responding to or could not tolerate TNF-blocker medicines.
- To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are ready for systemic therapy or phototherapy and are under the care of a doctor who will decide if other systemic therapies are less appropriate.
- To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) in adults.
The information contained in this section of the site is intended for US Healthcare Professionals only. Select “OK” if you are a US Healthcare Professional.
Meet Hulio
Yes, having a chronic condition might feel like a lot. But HULIO is here to
help you manage it. Now that's good news.
Built with you in mind
The easy-to-use, 2-click HULIO prefilled pen makes starting treatment as simple as “click, click, go!”1 Just push the device against the skin to trigger the injection and watch the indicator display your progress. There is no button to press.2
HULIO is also available in 20 mg and 40 mg prefilled syringes.
Your prefilled pen or syringe may not include the HULIO logo.
Protective Cap
Covers the needle for your safety
Citrate Free
Minimizes injection site pain
Viewing Window
Shows progress of injection
2 Audible Clicks
Confirms start and end of injection
Plastic Design
Reduces risk of breaking
Made Without Natural Rubber Latex
Reduces allergic reactions
Hulio is a biosimilar to Humira® (adalimumab)
A biosimilar is a biologic drug that’s very similar to the original approved medicine. Since it’s nearly an exact copy of the original, there are no clinically meaningful differences between the two drugs.2,3
like Humira
relief like Humira
as Humira
Hulio helps treat the inflammation
associated with your condition
HULIO works by blocking a certain protein in the body called TNF-α. Having too much
TNF-α causes inflammation that can increase disease symptoms, anywhere from joints to GI
tract to skin. By blocking TNF-α, adalimumab has been shown to reduce the inflammation.2
-
Rheumatology
Moderate to Severe
Rheumatoid Arthritis
in adults
ACTIVE
Psoriatic Arthritis
in adults
active
Ankylosing Spondylitis
in adults
Moderate to Severe Polyarticular
Juvenile Idiopathic Arthritis
in children 2 years of age and older
-
Dermatology
Moderate to Severe Chronic
Plaque Psoriasis
in adults
Moderate to Severe
Hidradenitis Suppurativa
in adults
-
Gastroenterology
Moderate to Severe
Crohn’s Disease
in adults and children 6 years of age and older
Moderate to Severe
Ulcerative Colitis
in adults
-
Ophthalmology
NON-INFECTIOUS
Uveitis
in adults
Hulio helps treat the inflammation
associated with your condition
HULIO works by blocking a certain protein in the body called TNF-α. Having too much
TNF-α causes inflammation that can increase disease symptoms, anywhere from joints to GI
tract to skin. By blocking TNF-α, adalimumab has been shown to reduce the inflammation.2
Moderate to Severe
Rheumatoid Arthritis
in adults
ACTIVE
Psoriatic Arthritis
in adults
active
Ankylosing Spondylitis
in adults
Moderate to Severe Polyarticular
Juvenile Idiopathic Arthritis
in children 2 years of age and older
Moderate to Severe Chronic
Plaque Psoriasis
in adults
Moderate to Severe
Hidradenitis Suppurativa
in adults
Moderate to Severe
Crohn’s Disease
in adults and children 6 years of age and older
Moderate to Severe
Ulcerative Colitis
in adults
NON-INFECTIOUS
Uveitis
in adults
Biosimilars aren’t just what we do—they’re all we do
Each year, biosimilars save the US healthcare system over $5 billion.*4 By increasing the availability of high-quality biosimilars such as HULIO here and around the world, Biocon Biologics aims to help make a meaningful difference for you.
5.5 MILLION PATIENTStreated in over 100 countries
8 BIOSIMILARSavailable worldwide
20+ BIOSIMILARSapproved or in development
Learn more about Biocon Biologics here.
*Estimated decrease in direct spending on biologic drugs from 2014 through 2024.
References: 1. Serrecchia T, Waller KA, Ishikawa T, Muniz R, Varricchione TR. Human factors validation for a rheumatoid arthritis auto-injector for the adalimumab biosimilar FKB327. Int J Hum Factors Ergon. 2020;7(2):144-160. 2. HULIO. Prescribing information. Biocon Biologics Inc; 2023. 3. US Food and Drug Administration. Biosimilar basics for patients. 2023. Accessed April 21, 2023. https://www.fda.gov/drugs/biosimilars/biosimilar-basics-patients 4. Mulcahy AW, Hlavka JP, Case SR. Biosimilar cost savings in the United States: initial experience and future potential. Rand Health Q. 2018;7(4):3.
Important Safety Information
What is the most important information I should know about HULIO® (adalimumab-fkjp)?
You should discuss the potential benefits and risks of HULIO with your doctor. HULIO is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HULIO if you have any kind of infection unless your doctor says it is okay.
Serious infections
- Serious infections have happened in people taking adalimumab products. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HULIO and check you closely for signs and symptoms of TB during treatment with HULIO, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
Cancer
- For children and adults taking TNF blockers, including HULIO, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers, including HULIO, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated. Tell your doctor if you have a bump or open sore that doesn’t heal.
What should I tell my doctor BEFORE starting HULIO?
Tell your doctor about all of your health conditions, including if you:
- Have an infection, are being treated for infection, or have symptoms of an infection
- Get a lot of infections or infections that keep coming back
- Have diabetes
- Have TB or have been in close contact with someone with TB, or were born in, lived in, or traveled where there is more risk for getting TB
- Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis. These infections may happen or become more severe if you use HULIO. Ask your doctor if you are unsure if you have lived in an area where these infections are common.
- Have or have had hepatitis B
- Are scheduled for major surgery
- Have or have had cancer
- Have numbness or tingling or a nervous system disease such as multiple sclerosis or Guillain-Barré syndrome
- Have or had heart failure
- Have recently received or are scheduled to receive a vaccine. HULIO patients may receive vaccines, except for live vaccines. Children should be brought up to date on all vaccines before starting HULIO
- Are allergic to HULIO or to any of its ingredients
- Are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed
- Have a baby and you were using HULIO during your pregnancy. Tell your baby’s doctor before your baby receives any vaccines
Also tell your doctor about all the medicines you take. You should not take HULIO with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (6-mercaptopurine, 6-MP).
What should I watch for AFTER starting HULIO?
HULIO can cause serious side effects, including:
- Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle.
- Hepatitis B infection in carriers of the virus. Symptoms include muscle aches, feeling very tired, dark urine, skin or eyes that look yellow, little or no appetite, vomiting, clay-colored bowel movements, fever, chills, stomach discomfort, and skin rash.
- Allergic reactions. Symptoms of a serious allergic reaction include hives, trouble breathing, and swelling of your face, eyes, lips, or mouth.
- Nervous system problems. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
- Blood problems (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
- Heart failure (new or worsening). Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain.
- Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or rash on your cheeks or arms that gets worse in the sun.
- Liver problems. Symptoms include feeling very tired, skin or eyes that look yellow, poor appetite or vomiting, and pain on the right side of your stomach (abdomen). These problems can lead to liver failure and death.
- Psoriasis (new or worsening). Symptoms include red scaly patches or raised bumps that are filled with pus.
Call your doctor or get medical care right away if you develop any of the above symptoms.
The most common side effects of HULIO include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, and rash. These are not all of the possible side effects with HULIO. Tell your doctor if you have any side effect that bothers you or that does not go away.
Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:
- Fever, sweats, or chills
- Muscle aches
- Cough
- Shortness of breath
- Blood in phlegm
- Weight loss
- Warm, red, or painful skin or sores on your body
- Diarrhea or stomach pain
- Burning when you urinate
- Urinating more often than normal
- Feeling very tired
If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call . Please see Prescribing Information and Medication Guide.
APPROVED USES
HULIO is a prescription medicine used:
-
To reduce the signs and symptoms
of:
- Moderate to severe rheumatoid arthritis (RA) in adults. HULIO can be used alone, with methotrexate, or with certain other medicines. HULIO may prevent further damage to your bones and joints and may help your ability to perform daily activities.
- Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. HULIO can be used alone or with methotrexate.
- Psoriatic arthritis (PsA) in adults. HULIO can be used alone or with certain other medicines. HULIO may prevent further damage to your bones and joints and may help your ability to perform daily activities.
- Ankylosing spondylitis (AS) in adults.
- Moderate to severe hidradenitis suppurativa (HS) in adults.
- To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older.
- To treat moderate to severe ulcerative colitis (UC) in adults. It is not known if adalimumab products are effective in people who stopped responding to or could not tolerate TNF-blocker medicines.
- To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are ready for systemic therapy or phototherapy and are under the care of a doctor who will decide if other systemic therapies are less appropriate.
- To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) in adults.
Important Safety Information
What is the most important information I should know about HULIO® (adalimumab-fkjp)?
You should discuss the potential benefits and risks of HULIO with your doctor. HULIO is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HULIO if you have any kind of infection unless your doctor says it is okay.
Serious infections
- Serious infections have happened in people taking adalimumab products. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HULIO and check you closely for signs and symptoms of TB during treatment with HULIO, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
Cancer
- For children and adults taking TNF blockers, including HULIO, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers, including HULIO, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated. Tell your doctor if you have a bump or open sore that doesn’t heal.
What should I tell my doctor BEFORE starting HULIO?
Tell your doctor about all of your health conditions, including if you:
- Have an infection, are being treated for infection, or have symptoms of an infection
- Get a lot of infections or infections that keep coming back
- Have diabetes
- Have TB or have been in close contact with someone with TB, or were born in, lived in, or traveled where there is more risk for getting TB
- Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis. These infections may happen or become more severe if you use HULIO. Ask your doctor if you are unsure if you have lived in an area where these infections are common.
- Have or have had hepatitis B
- Are scheduled for major surgery
- Have or have had cancer
- Have numbness or tingling or a nervous system disease such as multiple sclerosis or Guillain-Barré syndrome
- Have or had heart failure
- Have recently received or are scheduled to receive a vaccine. HULIO patients may receive vaccines, except for live vaccines. Children should be brought up to date on all vaccines before starting HULIO
- Are allergic to HULIO or to any of its ingredients
- Are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed
- Have a baby and you were using HULIO during your pregnancy. Tell your baby’s doctor before your baby receives any vaccines
Also tell your doctor about all the medicines you take. You should not take HULIO with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (6-mercaptopurine, 6-MP).
What should I watch for AFTER starting HULIO?
HULIO can cause serious side effects, including:
- Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle.
- Hepatitis B infection in carriers of the virus. Symptoms include muscle aches, feeling very tired, dark urine, skin or eyes that look yellow, little or no appetite, vomiting, clay-colored bowel movements, fever, chills, stomach discomfort, and skin rash.
- Allergic reactions. Symptoms of a serious allergic reaction include hives, trouble breathing, and swelling of your face, eyes, lips, or mouth.
- Nervous system problems. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
- Blood problems (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
- Heart failure (new or worsening). Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain.
- Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or rash on your cheeks or arms that gets worse in the sun.
- Liver problems. Symptoms include feeling very tired, skin or eyes that look yellow, poor appetite or vomiting, and pain on the right side of your stomach (abdomen). These problems can lead to liver failure and death.
- Psoriasis (new or worsening). Symptoms include red scaly patches or raised bumps that are filled with pus.
Call your doctor or get medical care right away if you develop any of the above symptoms.
The most common side effects of HULIO include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, and rash. These are not all of the possible side effects with HULIO. Tell your doctor if you have any side effect that bothers you or that does not go away.
Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:
- Fever, sweats, or chills
- Muscle aches
- Cough
- Shortness of breath
- Blood in phlegm
- Weight loss
- Warm, red, or painful skin or sores on your body
- Diarrhea or stomach pain
- Burning when you urinate
- Urinating more often than normal
- Feeling very tired
If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call . Please see Prescribing Information and Medication Guide.
APPROVED USES
HULIO is a prescription medicine used:
-
To reduce the signs and symptoms
of:
- Moderate to severe rheumatoid arthritis (RA) in adults. HULIO can be used alone, with methotrexate, or with certain other medicines. HULIO may prevent further damage to your bones and joints and may help your ability to perform daily activities.
- Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. HULIO can be used alone or with methotrexate.
- Psoriatic arthritis (PsA) in adults. HULIO can be used alone or with certain other medicines. HULIO may prevent further damage to your bones and joints and may help your ability to perform daily activities.
- Ankylosing spondylitis (AS) in adults.
- Moderate to severe hidradenitis suppurativa (HS) in adults.
- To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older.
- To treat moderate to severe ulcerative colitis (UC) in adults. It is not known if adalimumab products are effective in people who stopped responding to or could not tolerate TNF-blocker medicines.
- To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are ready for systemic therapy or phototherapy and are under the care of a doctor who will decide if other systemic therapies are less appropriate.
- To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) in adults.